Skip to content

Use of virtual reality in port implantation to reduce perioperative anxiety and pain - the randomized controlled VIP pilot study

Use of virtual reality in port implantation to reduce perioperative anxiety and pain - the randomized controlled VIP pilot study - VIP pilot

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00028508
Enrollment
120
Registered
2022-03-15
Start date
2022-04-29
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OPS 5-399.5 Implantation or change of venous catheter systems (e.g. for chemotherapy or pain therapy) Patients scheduled for port implantation (independent from underlying disease)

Interventions

Group 1: Port implantation with use of virtual reality goggles in addition to local anaesthesia (± iv analgetics/sedation) Group 2: Conventional port implantation under local anesthesia (± intravenous

Sponsors

Universitätsklinikum Ulm Abteilung für Allgemein- und Viszeralchirurgie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age =18 years 2. Scheduled for elective intravenous port implantation without general anesthesia for any indication 3. Ability to understand the nature and extent of the trial and to give written informed consent. 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. American Society of Anaesthesiologists (ASA) grade > 3 2. Chronic pain 3. Missing cognitive capability of following the virtual reality procedure (e.g. patients with dementia, psychotic episodes or psychiatric pathologies prohibiting VR use) 4. Uncontrolled epilepsy or visually triggered epileptic seizures in the patient's history 5. Auditory and/or visual disorders implying a contraindication for the use of VR 6. Hearing aids and cardiac pacemakers/defibrillators 7. Participation in another intervention-trial with interference of intervention and/or outcome of this study

Design outcomes

Primary

MeasureTime frame
Peri- and postoperative pain Perioperative anxiety Perioperative drug consumption: consumption of analgesics and sedation

Secondary

MeasureTime frame
Patient’s satisfaction Patient’s tolerability of the procedure Occurrence of postoperative nausea or vomiting Surgeon's satisfaction Duration of procedure Postoperative complications until POD 30

Countries

Germany

Contacts

Public ContactSandra Graf

Klinik für Allgemein- und ViszeralchirurgieUniversitätsklinikum Ulm

sandra.graf@uniklinik-ulm.de0731 500 53502

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 8, 2026